NCT04650672View on ClinicalTrials.gov

Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

December 8, 2020

Primary Completion Date

August 4, 2021

Study Completion Date

September 30, 2021

Conditions
Retinal Neovascularization
Trial Locations (2)

63017

Pepose Vision Institute, St Louis

02114

Ophthalmic Cons. of Boston, Boston

Sponsors

Lead Sponsor

Notal Vision Inc.
All Listed Sponsors
lead

Notal Vision Inc.

INDUSTRY

NCT04650672 - Daily Testing at Home by NV-AMD Subjects With Notal Home OCT. | Biotech Hunter | Biotech Hunter